Small Biotech Catapults To Record High On $10.6 Billion Deal - Investor's Business Daily
GSK made an all-cash bid to buy the small cancer-focused biotech company for $10.6 billion.
Search Group
Share To
Comments
About Screade
Screade® Inc. version c7e113a, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments